Sangamo Therapeutics(SGMO) - 2024 Q1 - Quarterly Results

Exhibit 99.1 SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS RICHMOND, California, May 9, 2024 - Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported business highlights and first quarter 2024 financial results. "Sangamo continues to progress its neurology-focused genomic medicine pipeline as most recently showcased at the 27 ASGCT Annual Meeting, with foundational advances across our epigenetic regulation programs and capsid ...